PRAX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Praxis Precision Medicines Inc

NASDAQ | PRAX

174.95

USD

$0.00

(

0.00%

)

At Close (As of Oct 24, 2025)

$4.59B

Market Cap

-

P/E Ratio

-12.41

EPS

$205.89

52 Week High

$26.70

52 Week Low

HEALTHCARE

Sector

PRAX Chart

Recent Chart
Price Action

PRAX Technicals

Tags:

PRAX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $8.2M
Total Revenue $8.6M
Cost Of Revenue $358K
Costof Goods And Services Sold $358K
Operating Income -$200M
Selling General And Administrative $56M
Research And Development $152M
Operating Expenses $209M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $358K
Income Before Tax -$183M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$183M
Comprehensive Income Net Of Tax -
Ebit -$200M
Ebitda -$200M
Net Income -$183M

Revenue & Profitability

Earnings Performance

PRAX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $483M
Total Current Assets $404M
Cash And Cash Equivalents At Carrying Value $215M
Cash And Short Term Investments $215M
Inventory -
Current Net Receivables -
Total Non Current Assets $79M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $77M
Short Term Investments $177M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $38M
Total Current Liabilities $38M
Current Accounts Payable $13M
Deferred Revenue -
Current Debt -
Short Term Debt $1.3M
Total Non Current Liabilities $110K
Capital Lease Obligations $1.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.4M
Other Current Liabilities $24M
Other Non Current Liabilities -
Total Shareholder Equity $445M
Treasury Stock -
Retained Earnings -$837M
Common Stock $14K
Common Stock Shares Outstanding $18M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$132M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $358K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$248M
Cashflow From Financing $514M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$183M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $8.2M
Total Revenue $8.6M
Cost Of Revenue $358K
Costof Goods And Services Sold $358K
Operating Income -$200M
Selling General And Administrative $56M
Research And Development $152M
Operating Expenses $209M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $358K
Income Before Tax -$183M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$183M
Comprehensive Income Net Of Tax -
Ebit -$200M
Ebitda -$200M
Net Income -$183M

PRAX News

PRAX Profile

Praxis Precision Medicines Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing innovative therapies for central nervous system disorders linked to neuronal imbalance. Utilizing a proprietary scientific platform, Praxis aims to identify and advance novel treatments for a range of neurological conditions, prioritizing those with significant unmet medical needs. With a strong pipeline and a commitment to enhancing patient outcomes and quality of life, the company is well-positioned to make a meaningful impact in the biopharmaceutical sector.

WGRX
+194.11%
$1.18
TOVX
+110.20%
$0.71
YYAI
-15.73%
$0.07
BYND
+8.08%
$3.06
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
VIVK
+25.55%
$0.32
INTC
+0.99%
$38.53
YDKG
-19.77%
$0.05
F
+10.14%
$13.59
ADAP
-3.44%
$0.07
WTO
-7.04%
$0.06
NEUP
+52.46%
$6.17
AXDX
-61.36%
$0.03
ADTX
-5.35%
$0.28
QUBT
+7.19%
$15.94
BITF
+9.24%
$4.55
NVDA
+1.77%
$185.38
VZ
-3.51%
$38.40
BURU
+3.07%
$0.35
RGTI
+2.48%
$40.57
PLUG
+1.61%
$2.92
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
SCNX
-35.00%
$1.69
GPUS
-0.28%
$0.38
TSLA
-2.28%
$438.71
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
QBTS
+6.66%
$33.12
AMD
+7.54%
$252.72
AAL
+6.45%
$13.59
CUTR
-10.19%
$0.09
DVLT
+15.10%
$2.58
WLGS
-5.57%
$0.04
ETWO
0.00%
$3.30
SOFI
+3.86%
$29.16
ONDS
+7.43%
$7.58
RIG
+4.11%
$4.05
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
KDLY
+10.41%
$0.79
OSCR
-3.68%
$19.62
BMNR
+2.41%
$49.19
NOK
+0.32%
$6.18
RANI
-13.45%
$2.09
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
ASST
+4.54%
$0.90
KLG
-9.05%
$13.35
GRYP
-10.38%
$1.38
PLTR
+2.51%
$185.02
AMC
-0.69%
$2.71
CAN
+4.26%
$1.83
MODV
-25.22%
$0.43
LXEH
+24.60%
$0.56
AIRE
-13.94%
$0.84
OKLO
+3.81%
$124.70
IREN
+9.91%
$61.40
SNAP
+0.57%
$7.91
EOSE
-4.64%
$14.36
ETHD
-2.51%
$3.87
NRXS
-7.72%
$3.52
NVTS
+6.26%
$14.46
NBIS
+7.64%
$106.16
IONQ
+4.21%
$61.87
LAES
+2.70%
$5.87
BMY
-1.26%
$43.83
GNTA
+86.06%
$6.01
MARA
+3.64%
$19.92
CSCO
-0.55%
$70.27
SAND
-6.04%
$12.12
GRAB
+1.16%
$5.78
RXRX
+0.80%
$5.77
APLD
+4.59%
$34.91
SHOT
-74.37%
$0.39
IONZ
-9.04%
$3.62
ZAPP
-46.30%
$0.15
LVS
+12.38%
$56.89
CIFR
+12.19%
$19.36
BTBT
+5.34%
$3.91
AMZN
+0.92%
$223.14
WULF
+7.18%
$13.80
HOOD
+2.75%
$138.02
KDP
+0.58%
$27.55
SMCI
+1.98%
$48.87
NGD
+0.62%
$6.46
NUAI
+18.73%
$4.69
AAPL
+1.32%
$263.01
BAC
+1.63%
$52.60
DNN
+1.09%
$2.76
CLSK
+7.01%
$18.91
NIO
-0.21%
$6.87
IAG
-0.08%
$12.04
QLGN
+5.37%
$3.53
NEHC
+4.22%
$3.95
QS
+2.69%
$15.05
DECK
-11.86%
$90.37
CRML
+14.21%
$15.57
BREA
+36.64%
$11.41
WGRX
+194.11%
$1.18
TOVX
+110.20%
$0.71
YYAI
-15.73%
$0.07
BYND
+8.08%
$3.06
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
VIVK
+25.55%
$0.32
INTC
+0.99%
$38.53
YDKG
-19.77%
$0.05
F
+10.14%
$13.59
ADAP
-3.44%
$0.07
WTO
-7.04%
$0.06
NEUP
+52.46%
$6.17
AXDX
-61.36%
$0.03
ADTX
-5.35%
$0.28
QUBT
+7.19%
$15.94
BITF
+9.24%
$4.55
NVDA
+1.77%
$185.38
VZ
-3.51%
$38.40
BURU
+3.07%
$0.35
RGTI
+2.48%
$40.57
PLUG
+1.61%
$2.92
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
SCNX
-35.00%
$1.69
GPUS
-0.28%
$0.38
TSLA
-2.28%
$438.71
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
QBTS
+6.66%
$33.12
AMD
+7.54%
$252.72
AAL
+6.45%
$13.59
CUTR
-10.19%
$0.09
DVLT
+15.10%
$2.58
WLGS
-5.57%
$0.04
ETWO
0.00%
$3.30
SOFI
+3.86%
$29.16
ONDS
+7.43%
$7.58
RIG
+4.11%
$4.05
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
KDLY
+10.41%
$0.79
OSCR
-3.68%
$19.62
BMNR
+2.41%
$49.19
NOK
+0.32%
$6.18
RANI
-13.45%
$2.09
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
ASST
+4.54%
$0.90
KLG
-9.05%
$13.35
GRYP
-10.38%
$1.38
PLTR
+2.51%
$185.02
AMC
-0.69%
$2.71
CAN
+4.26%
$1.83
MODV
-25.22%
$0.43
LXEH
+24.60%
$0.56
AIRE
-13.94%
$0.84
OKLO
+3.81%
$124.70
IREN
+9.91%
$61.40
SNAP
+0.57%
$7.91
EOSE
-4.64%
$14.36
ETHD
-2.51%
$3.87
NRXS
-7.72%
$3.52
NVTS
+6.26%
$14.46
NBIS
+7.64%
$106.16
IONQ
+4.21%
$61.87
LAES
+2.70%
$5.87
BMY
-1.26%
$43.83
GNTA
+86.06%
$6.01
MARA
+3.64%
$19.92
CSCO
-0.55%
$70.27
SAND
-6.04%
$12.12
GRAB
+1.16%
$5.78
RXRX
+0.80%
$5.77
APLD
+4.59%
$34.91
SHOT
-74.37%
$0.39
IONZ
-9.04%
$3.62
ZAPP
-46.30%
$0.15
LVS
+12.38%
$56.89
CIFR
+12.19%
$19.36
BTBT
+5.34%
$3.91
AMZN
+0.92%
$223.14
WULF
+7.18%
$13.80
HOOD
+2.75%
$138.02
KDP
+0.58%
$27.55
SMCI
+1.98%
$48.87
NGD
+0.62%
$6.46
NUAI
+18.73%
$4.69
AAPL
+1.32%
$263.01
BAC
+1.63%
$52.60
DNN
+1.09%
$2.76
CLSK
+7.01%
$18.91
NIO
-0.21%
$6.87
IAG
-0.08%
$12.04
QLGN
+5.37%
$3.53
NEHC
+4.22%
$3.95
QS
+2.69%
$15.05
DECK
-11.86%
$90.37
CRML
+14.21%
$15.57
BREA
+36.64%
$11.41
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.